0.4517USD-3.69%Mkt Cap: 9.94M $P/E: —1d ago
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-a…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap9.94M $
Enterprise Value6.59M $
Revenue (TTM)275.58K $
Gross Profit240.27K $
Net Income (TTM)-8.22M $
Revenue/Share0.0150 USD
Last Price0.4517 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.46
PEG—
EV/EBITDA-0.78
EV/Revenue23.91
P/S36.08
P/B3.23
EPS (TTM)-0.46
EPS (Forward)-0.31
52W Range
0.30509% of range2.000
52W High2.000 USD
52W Low0.3050 USD
Profitability
Gross Margin79.65%
Oper. Margin-14179.95%
EBITDA Margin0.00%
Profit Margin-2725.76%
ROE-219.38%
ROA-177.38%
Growth
Revenue Growth-63.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.96M $
CapEx (TTM)96.86K $
FCF Margin-816.70%
FCF Yield-22.64%
Net Debt-2.71M $
Net Debt/EBITDA0.32
Balance Sheet
Debt/Equity—
Current Ratio4.07
Quick Ratio3.40
Book Value/Sh0.1400 USD
Cash/Share0.1320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.000 USD
Upside (mean)+342.8%
Target Range2.000 USD – 2.000 USD
# Analysts1
Ownership
Shares Out.22.01M
Float17.98M
Insiders10.50%
Institutions4.89%
Short Interest
Short Ratio2.1d
Short % Float2.65%
Short % Out.2.51%
Shares Short540.63K
Short (prev mo.)1.18M
Technical
SMA 500.4114 (+9.8%)
SMA 2000.6799 (-33.6%)
Beta4.03
S&P 52W Chg20.25%
Avg Vol (30d)247.02K
Avg Vol (10d)334.18K
Technical Indicators
RSI (14)56.1
MACD0.0048
MACD Signal-0.0073
MACD Hist.+0.0121
BB Upper0.4715 USD
BB Middle0.3842 USD
BB Lower0.2970 USD
BB Width45.42%
ATR (14)0.0518 USD
Vol Ratio (20d)0.46x